Boehringer Ingelheim’s China headquarters announced in Shanghai on the 27th that the second-generation EGFR-targeted drug afatinib has been approved in China, bringing new hope to lung cancer patients in China. 170228-1 Lung cancer is one of the most common malignant tumors in China. T...

Notice of the General Office of the National Health and Family Planning Commission on Issuing the Technical Management Specifications for Hematopoietic Stem Cell Transplantation (2017 Edition) and other 15 "restricted clinical application" medical technical management specifications...

Regarding cancer, our body has a defense mechanism. From "sneezing" to "cancer", there will be 9 stages during this period-the body gives you 9 opportunities to prevent cancer, listen to the voice of the body, the body will know Fix it yourself. Get to know it quickly! No one likes to be sick, ...

With the approval of Premier Li Keqiang, the State Council recently issued the "Thirteenth Five-Year" National Science and Technology Innovation Plan (Guofa [2016] No. 43, hereinafter referred to as the "Plan"), which clearly put forward the guiding ideology, Overall requirements, ...

Although the 2015 ASCO conference has come to an end, the major studies at the conference have brought a lasting and profound impact on our clinical practice. This article summarizes the top 10 clinical decision-making changes brought about by ASCO 2015. 2015 ASCO Conference 1. Recom...